Latest Insider Transactions at Signify Health, Inc. (SGFY)
This section provides a real-time view of insider transactions for Signify Health, Inc. (SGFY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Signify Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Signify Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 16
2021
|
Sam Pettijohn Chief Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+50.0%
|
-
|
|
May 13
2021
|
Heather Brianne Dixon Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,002
+50.0%
|
-
|
|
Apr 01
2021
|
Stephen F Wiggins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,561
+0.07%
|
$11,122
$2.28 P/Share
|
|
Mar 31
2021
|
Stephen F Wiggins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
178,319
+1.12%
|
$356,638
$2.01 P/Share
|
|
Feb 16
2021
|
Laurel Douty EVP, Clinic. Ops, Care Srvces |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$240,000
$24.0 P/Share
|
|
Feb 16
2021
|
Matthew S. Holt Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Albert A Notini Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Kyle B. Peterson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Taj J. Clayton Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Kevin M Mcnamara Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Brandon H Hull Director |
BUY
Open market or private purchase
|
Direct |
13,900
+38.92%
|
$333,600
$24.0 P/Share
|
|
Feb 16
2021
|
Brandon H Hull Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Laurence Michael Orton Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
5,200
+50.0%
|
$124,800
$24.0 P/Share
|
|
Feb 16
2021
|
Adam Mc Ananey General Counsel and Secretary |
BUY
Open market or private purchase
|
Direct |
13,900
+26.98%
|
$333,600
$24.0 P/Share
|
|
Feb 16
2021
|
David Pierre Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
13,200
+50.0%
|
$316,800
$24.0 P/Share
|
|
Feb 16
2021
|
Vivian E. Riefberg Director |
BUY
Open market or private purchase
|
Direct |
13,900
+38.92%
|
$333,600
$24.0 P/Share
|
|
Feb 16
2021
|
Vivian E. Riefberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Marc D Rothman Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$24,000
$24.0 P/Share
|
|
Feb 16
2021
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
BUY
Open market or private purchase
|
Direct |
13,900
+11.03%
|
$333,600
$24.0 P/Share
|
|
Feb 16
2021
|
Stephen F Wiggins Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Bradford Kyle Armbrester Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
13,900
+50.0%
|
$333,600
$24.0 P/Share
|
|
Feb 16
2021
|
New Mountain Capital, L.L.C. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
23,748
+50.0%
|
-
|
|
Feb 12
2021
|
Peter Boumenot Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
186,038
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Taj J. Clayton Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,173
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Josh Builder Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
145,011
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Laurel Douty EVP, Clinic. Ops, Care Srvces |
BUY
Grant, award, or other acquisition
|
Direct |
145,042
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Kevin M Mcnamara Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,260,850
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Brandon H Hull Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,030,500
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Adam Mc Ananey General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
24,173
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Adam Mc Ananey General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
23,728
+50.0%
|
-
|
|
Feb 12
2021
|
David Pierre Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
772,875
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Vivian E. Riefberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,173
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Marc D Rothman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,837
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
BUY
Grant, award, or other acquisition
|
Direct |
506,975
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
BUY
Grant, award, or other acquisition
|
Direct |
98,214
+50.0%
|
-
|
|
Feb 12
2021
|
Stephen F Wiggins Director |
BUY
Grant, award, or other acquisition
|
Indirect |
4,048
+50.0%
|
-
|
|
Feb 12
2021
|
Stephen F Wiggins Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,697,691
+50.0%
|
-
|
|
Feb 12
2021
|
Bradford Kyle Armbrester Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
2,304,479
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Bradford Kyle Armbrester Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,686,599
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Bradford Kyle Armbrester Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
100
-100.0%
|
$100
$1.0 P/Share
|
|
Feb 12
2021
|
New Mountain Capital, L.L.C. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
42,905,113
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
New Mountain Capital, L.L.C. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
96,709,693
+50.0%
|
-
|